Antagonist anti-CD40 monoclonal antibodies and methods for their use

Details for Australian Patent Application No. 2011201529 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Long, Li; Luqman, Mohammad; Yabannavar, Asha; Zaror, Isabel; Chen, BaoLu; Lu, Xiaogfeng; Lee, Sang Hoon; Hurst, Deborah

Agent FB Rice

Pub. Number AU-B-2011201529

Parent 2004287879

Filing date 5 April 2011

Wipo publication date 28 April 2011

Acceptance publication date 1 November 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 38/20 Medicinal preparations containing peptides - Interleukins

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

21 April 2011 Complete Application Filed

28 April 2011 Application Open to Public Inspection

  Published as AU-B-2011201529

1 November 2012 Application Accepted

  Published as AU-B-2011201529

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201530-A gaming system server

2011201528-Dispenser and method for entraining powder in an airflow 537